News
Interactive Brokers' Sophisticated Clients and Automation-Heavy Approach Support Defensible Position
Interactive Brokers' business strategy has long been rooted in efficiency, automation, and superior order execution, and there's very little that would point toward a deviation from this foundation.
The WSJ Dollar Index is down 0.56 point or 0.58% today to 95.78 --Largest one-day point and percentage decline since Monday, April 21, 2025 --Off 8.90% from its record close of 105.14 hit Tuesday, ...
--Up 1.00% from its 52-week low of 140.613 hit Monday, Sept. 16, 2024 Looking at drug momentum, supply stability, and DTC growth, here’s what we think of Eli Lilly’s stock.
--Off 0.79% from its 52-week high of 1.1514 hit Monday, April 21, 2025 --Up 11.49% from its 52-week low of 1.0246 hit Monday, Jan. 13, 2025 Looking at drug momentum, supply stability, and DTC growth, ...
Dollar/Mexican peso: 19.5918 Mexican pesos per dollar (0.0510 dollar per Mexican peso) --Largest one-day percentage gain since Thursday, April 10, 2025 --Off 6.03% from its 52-week high of 20.8489 hit ...
The S&P/TSX Composite Index is up 88.08 points or 0.36% today to 24798.59 --Off 3.91% from its record close of 25808.25 hit Thursday, Jan. 30, 2025 ...
The IPC Indice de Precios Y Cotizaciones is up 260.01 points or 0.46% today to 56980.13 --Up 5481.23 points or 10.64% over the last nine trading days ...
The Bovespa Index is up 276.61 points or 0.21% today to 135015.89 --Largest six-day point and percentage gain since Friday, March 21, 2025 ...
However, when stocks rebounded on April 9, thanks to Trump announcing a 90-day pause on some tariffs, large-cap growth funds ...
NXP Semiconductors guided for revenue and earnings to continue to decline in the second quarter after logging lower profit and sales in the first quarter amid a volatile tariff environment.
More Americans feel pessimistic about their money, job prospects and the economy, according to an array of polling. Some people are acting on their worries, scrapping big-ticket purchase plans, like ...
Looking at drug momentum, supply stability, and DTC growth, here’s what we think of Eli Lilly’s stock.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results